Multiple Sclerosis

Use of MS Drug Expanded to Include Children

MONDAY, May 14, 2018 -- The U.S. Food and Drug Administration has expanded its approval of the multiple sclerosis drug Gilenya (fingolimod) to include children aged 10 and older.

It's the first multiple sclerosis drug approved for children, the agency said in a news release. The drug was approved in 2010 to treat adults with relapsing MS.

Read more
blog image
Multiple Sclerosis

Most multiple sclerosis patients shouldn't wait to start taking medication in the early stages of the disease, new guidelines say.

Read more
blog image
Multiple Sclerosis

Millions of young Americans have lived through the fatigue and discomfort of mononucleosis.

Read more